Lynx1 Capital Management as of Dec. 31, 2023
Portfolio Holdings for Lynx1 Capital Management
Lynx1 Capital Management holds 15 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alpine Immune Sciences (ALPN) | 28.6 | $73M | 3.8M | 19.06 | |
| Cabaletta Bio (CABA) | 18.8 | $48M | 2.1M | 22.70 | |
| Merus N V (MRUS) | 12.3 | $31M | 1.1M | 27.50 | |
| Tscan Therapeutics (TCRX) | 12.0 | $31M | 5.2M | 5.83 | |
| C4 Therapeutics Com Stk (CCCC) | 7.0 | $18M | 3.1M | 5.65 | |
| Stoke Therapeutics (STOK) | 6.1 | $16M | 3.0M | 5.26 | |
| Autolus Therapeutics Spon Ads (AUTL) | 4.7 | $12M | 1.9M | 6.44 | |
| Gh Research Ordinary Shares (GHRS) | 4.2 | $11M | 1.8M | 5.80 | |
| Kinnate Biopharma (KNTE) | 1.9 | $4.7M | 2.0M | 2.37 | |
| Silence Therapeutics Ads (SLN) | 1.6 | $4.1M | 236k | 17.37 | |
| Theseus Pharmaceuticals | 1.1 | $2.8M | 702k | 4.05 | |
| Pieris Pharmaceuticals (PIRS) | 0.7 | $1.8M | 9.8M | 0.18 | |
| Bionomics Ads (BNOX) | 0.5 | $1.2M | 824k | 1.48 | |
| Nektar Therapeutics (NKTR) | 0.4 | $1.1M | 1.9M | 0.56 | |
| Passage Bio (PASG) | 0.2 | $383k | 379k | 1.01 |
